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Alagille syndrome (AS) is also known as arteriohepatic dysplasia, Watson Miller syndrome, and syndromic bile duct paucity [1]. It is rare autosomal dominant genetic 
syndrome with incidence of 1 in 100,000 live births [2]. It occurs 
due to defects in components of the Notch signaling pathway, 
most commonly JAG 1 (ALGS1), in a small proportion of cases 
mutation in NOTCH2 (ALGS2) [3]. 60% of cases due to new 
mutation and 40% inherited from parents [4]. The five major 
manifestations include the paucity of interlobular bile ducts, 
characteristic facies, posterior embryotoxon, vertebral defects, 
and peripheral pulmonary stenosis [5].
CASE REPORT
A developmentally normal 14-month-old male toddler born 
of a non-consanguineous marriage presented with progressive 
jaundice since 4 months of age and was associated with 
generalized itching, high-colored urine which stains the cloth, 
and pale-colored stools. Similar history noted in sibling and died 
at the age of 13 months with bleeding manifestations. Antenatal, 
natal, and immediate post-natal history was non-contributory. 
On general examination, the child was stunted with a length of 
70 cm and undernourished with a weight of 6.5 kg (both were 
<3rd percentiles for are according to WHO charts), and weight for 
length was also <3rd percentile according to WHO charts.
The general physical examination showed broad forehead, 
deep-set eyes, depressed nose, pointed chin, multiple raised non-
itchy yellow-colored lesions over cheeks, and other body folds 
(Fig. 2). Mild pallor and icterus noted in the eyes, vitals were 
normal. On palpation of the abdomen, a firm non-tender, moderate 
hepatosplenomegaly was present (liver span 9 cm, soft and spleen 
6 cm). Ejection systolic murmur was heard over the aortic area. 
Provisional diagnosis of neonatal cholestasis was made, and the 
child was managed with symptomatic and supportive treatment. 
Ophthalmologic examination with slit lamp showed posterior 
embryotoxon.
Investigations showed anemia (Hb: 7.5 g/dl), conjugated 
hyperbilirubinemia (total/direct/indirect: 32/24/8 mg/dl), raised 
serum glutamic pyruvic transaminase (120 IU/L), serum glutamic 
oxaloacetic transaminase (300 IU/L), ALP (390 IU/L), and GGT 
(600 IU/L). Serum triglycerides were elevated (215 mg/dl), and 
HBsAg and anti-hepatitis C virus antibody were negative. His chest 
X-ray was normal, and 2D echocardiography was normal. Skeletal 
survey was also normal. Abdominal ultrasound showed moderate 
hepatomegaly with liver parenchymal changes and crossed fused 
ectopia of the left kidney (Figure 3). Liver biopsy was performed 
and sent for histopathological examination which showed paucity 
of the bile ducts (Figure 1). With the above features, a diagnosis of 
AS was made. We could not perform genetic studies as this facility 
was not available. The child was managed symptomatically; 
however, he developed hemorrhagic manifestations and died later.
DISCUSSION
AS is the syndrome of paucity of intrahepatic bile ducts. It is 
probably inherited in an autosomal dominant fashion with variable 
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expression [6]. The disease is characterized by a peculiar facies, 
with abnormalities of the liver, heart, eye, skeleton, and kidney. 
Mild to moderate mental retardation may be present. Individuals 
commonly present before 6 months of age for either neonatal 
jaundice or cardiac murmurs; later, they may present with poor 
linear growth, with a broad forehead, pointed chin, deep-set eyes, 
and elongated nose with a bulbous tip. Hepatic disease is the 
key factor in AS, and the long-standing cholestasis and resultant 
hypercholesterolemia cause cutaneous manifestations of jaundice, 
pruritus, and widespread xanthomata [5].
Emerick et al. conducted a study on 92 patients with AS, 
showed paucity of interlobular bile ducts in 85%, cholestasis 
in 96%, cardiac murmurs in 97%, butterfly vertebra in 51%, 
posterior embryotoxon in the eye in 78%, and characteristic facies 
in 96% of the cases [7]. In a study by Shendge et al., case had 
three of the five major features of the syndrome with no vertebral 
or ophthalmologic defects. This form of “partial” or “incomplete” 
AS has also been reported in the Indian literature by Shendge 
et al. [8]. Nigale et al. reported an Indian girl with AS who had 
bilateral corneal opacity, mental retardation, typical facies, cardiac 
murmur, xanthomatosis, and cholestatic jaundice [9]. In our case, 
the child was having 3 out of five major characteristic features 
including the paucity of interlobular bile ducts, characteristic 
facies, and posterior embryotoxon along with minor features such 
as renal anomalies and xanthomas.
Long-term prognosis of AS is uncertain. Surgical treatment 
of choice is liver transplantation. Rapid resolution of widespread 
xanthomata has been reported in AS following orthotopic liver 
transplant [6]. Pruritus, often recalcitrant to medical therapy, has 
been reported to improve with cholestyramine (12-15 g/day) [2]. 
The estimated 20-year survival rates are 80% for those not 
requiring liver transplant and 60% for those requiring it [7]. 
The common factors affecting mortality are congenital heart 
disease, hepatic cirrhosis, intracranial bleeding, and renal 
abnormalities [10,11].
CONCLUSION
The above case report stresses the need to look for any dysmorphic 
features in a case of neonatal cholestasis as AS, though rare, is a 
cause of neonatal cholestasis.
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Figure 1: Liver biopsy findings (arrowheads show arteries and 
arrows showing lymphocytic infiltrate)
Figure 2: Child with Alagille syndrome showing characteristic facies 
(triangular facies, wide-spaced eyes, pointed chin, and low-set ears)
Figure 3: Ultrasonography abdomen and pelvis showing crossed 
fused ectopic left kidney
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